These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37713183)

  • 1. Characteristics of Complement Protein Deposition in Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition.
    Liu MY; Yu XJ; Wang SX; Li Y; Xing GL; Chen M; Zhou FD; Zhao MH
    Clin J Am Soc Nephrol; 2023 Dec; 18(12):1573-1582. PubMed ID: 37713183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.
    Liu M; Yu X; Wang S; Qin A; Zhou F; Zhao M
    J Nephrol; 2022 Dec; 35(9):2363-2372. PubMed ID: 35460458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation products in the circulation and urine of primary membranous nephropathy.
    Zhang MF; Huang J; Zhang YM; Qu Z; Wang X; Wang F; Meng LQ; Cheng XY; Cui Z; Liu G; Zhao MH
    BMC Nephrol; 2019 Aug; 20(1):313. PubMed ID: 31399080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement Activation Is Associated With Crescents in IgA Nephropathy.
    Wang Z; Xie X; Li J; Zhang X; He J; Wang M; Lv J; Zhang H
    Front Immunol; 2021; 12():676919. PubMed ID: 34594322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.
    Gou SJ; Yuan J; Wang C; Zhao MH; Chen M
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1884-91. PubMed ID: 24115193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone.
    Nasr SH; Larsen CP; Sirac C; Theis JD; Domenger C; Chauvet S; Javaugue V; Hogan JJ; Said SM; Dasari S; Vrana JA; McPhail ED; Cornell LD; Vilaine E; Massy ZA; Boffa JJ; Buob D; Toussaint S; Guincestre T; Touchard G; D'Agati VD; Leung N; Bridoux F
    Kidney Int; 2020 Mar; 97(3):589-601. PubMed ID: 32001067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement in ANCA-associated glomerulonephritis.
    Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
    Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation in patients with diabetic nephropathy.
    Li XQ; Chang DY; Chen M; Zhao MH
    Diabetes Metab; 2019 Jun; 45(3):248-253. PubMed ID: 29729954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular deposition of mannose-binding lectin in human glomerulonephritis.
    Lhotta K; Würzner R; König P
    Nephrol Dial Transplant; 1999 Apr; 14(4):881-6. PubMed ID: 10328463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy.
    Endo M; Ohi H; Ohsawa I; Fujita T; Matsushita M; Fujita T
    Nephrol Dial Transplant; 1998 Aug; 13(8):1984-90. PubMed ID: 9719152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy.
    Endo M; Fuke Y; Tamano M; Hidaka M; Ohsawa I; Fujita T; Ohi H
    Nephron Clin Pract; 2004; 97(4):c147-53. PubMed ID: 15331938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune-complexes and complement activation through the classical pathway in myeloperoxidase-ANCA-associated glomerulonephritis.
    Kojima T; Inoue D; Wajima T; Uchida T; Yamada M; Ohsawa I; Oda T
    Ren Fail; 2022 Dec; 44(1):714-723. PubMed ID: 35491890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation profile of patients with primary focal segmental glomerulosclerosis.
    Huang J; Cui Z; Gu QH; Zhang YM; Qu Z; Wang X; Wang F; Cheng XY; Meng LQ; Liu G; Zhao MH
    PLoS One; 2020; 15(6):e0234934. PubMed ID: 32569286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
    Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
    BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronological change of renal pathological findings in the proliferative glomerulonephritis with monoclonal IgG deposits considered to have recurred early after kidney transplantation.
    Katsuno T; Kato M; Fujita T; Tsuboi N; Hattori R; Ito Y; Maruyama S
    CEN Case Rep; 2019 Aug; 8(3):151-158. PubMed ID: 30805792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of recurrent proliferative glomerulonephritis with monoclonal IgG deposits or de novo C3 glomerulonephritis after kidney transplantation.
    Tamura T; Unagami K; Okumi M; Kakuta Y; Horita S; Ishida H; Koike J; Honda K; Tanabe K; Nitta K
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():76-80. PubMed ID: 29968411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C4 Glomerulopathy: A Disease Entity Associated With C4d Deposition.
    Sethi S; Quint PS; O'Seaghdha CM; Fervenza FC; Bijol V; Dorman A; Dasari S; Smith RJ; Kurtin PJ; Rennke HG
    Am J Kidney Dis; 2016 Jun; 67(6):949-53. PubMed ID: 26896898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease.
    Ma R; Cui Z; Liao YH; Zhao MH
    J Clin Immunol; 2013 Jan; 33(1):172-8. PubMed ID: 22941511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement Alternative Pathway׳s Activation in Patients With Lupus Nephritis.
    Song D; Guo WY; Wang FM; Li YZ; Song Y; Yu F; Zhao MH
    Am J Med Sci; 2017 Mar; 353(3):247-257. PubMed ID: 28262211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease.
    Ma R; Cui Z; Hu SY; Jia XY; Yang R; Zheng X; Ao J; Liu G; Liao YH; Zhao MH
    PLoS One; 2014; 9(3):e91250. PubMed ID: 24658070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.